Jianpeng Cai

Shanghai Key Laboratory Of Infectious Diseases And Biosafety Emergency Response
Shanghai, 200040, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Retraction notice to "Aging brought additional immune response alterations after breakthrough infections with the Omicron BA.5/BF.7 variants: Protein immune mechanism" [Int. J. Biol. Macromol. 281 (2024) 136183].

Retraction notice to "Aging brought additional immune response alterations after breakthrough infections with the Omicron BA.5/BF.7 variants: Protein immune mechanism" [Int. J. Biol. Macromol. 281 (2024) 136183].

Journal: International journal of biological macromolecules

Published: July 21, 2026

Natural history of latent brucellosis and diagnostic performance of B-SPOT: a 24-month prospective cohort study based on large-scale screening in northern China.

Natural history of latent brucellosis and diagnostic performance of B-SPOT: a 24-month prospective cohort study based on large-scale screening in northern China.

Journal: Emerging microbes & infections

Published: March 17, 2026

Meta-transcriptomics Reveals Dysbiosis of the Respiratory Microbiome in Older Adults with Long COVID.

Meta-transcriptomics Reveals Dysbiosis of the Respiratory Microbiome in Older Adults with Long COVID.

Journal: Research (Washington, D.C.)

Published: December 29, 2024

Aging brought additional immune response alterations after breakthrough infections with the Omicron BA.5/BF.7 variants: Protein immune mechanism.

Aging brought additional immune response alterations after breakthrough infections with the Omicron BA.5/BF.7 variants: Protein immune mechanism.

Journal: International journal of biological macromolecules

Published: August 06, 2024

Integrated multi-omics characterization across clinically relevant subgroups of long COVID.

Integrated multi-omics characterization across clinically relevant subgroups of long COVID.

Journal: National science review

Published: August 03, 2024

Real-world effectiveness and safety of Baloxavir Marboxil or Oseltamivir in outpatients with uncomplicated influenza A: an ambispective, observational, multi-center study.

Real-world effectiveness and safety of Baloxavir Marboxil or Oseltamivir in outpatients with uncomplicated influenza A: an ambispective, observational, multi-center study.

Journal: Frontiers in microbiology

Published: May 05, 2024

Multi-omics landscapes reveal heterogeneity in long COVID patients characterized with enhanced neutrophil activity.

Multi-omics landscapes reveal heterogeneity in long COVID patients characterized with enhanced neutrophil activity.

Journal: Journal of translational medicine

Published: March 22, 2024

Viral load dynamics in asymptomatic and symptomatic patients during Omicron BA.2 outbreak in Shanghai, China, 2022: A longitudinal cohort study.

Viral load dynamics in asymptomatic and symptomatic patients during Omicron BA.2 outbreak in Shanghai, China, 2022: A longitudinal cohort study.

Journal: Virologica Sinica

Published: January 31, 2024

Transcriptional profiling of human peripheral blood mononuclear cells in household contacts of pulmonary tuberculosis patients provides insights into mechanisms of Mycobacterium tuberculosis control and elimination.

Transcriptional profiling of human peripheral blood mononuclear cells in household contacts of pulmonary tuberculosis patients provides insights into mechanisms of Mycobacterium tuberculosis control and elimination.

Journal: Emerging microbes & infections

Published: December 13, 2023

Risk of reinfection and severity with the predominant BA.5 Omicron subvariant China, from December 2022 to January 2023.

Risk of reinfection and severity with the predominant BA.5 Omicron subvariant China, from December 2022 to January 2023.

Journal: Emerging microbes & infections

Published: December 06, 2023

Neutralization against Omicron subvariants after BA.5/BF.7 breakthrough infection weakened as virus evolution and aging despite repeated prototype-based vaccination1.

Neutralization against Omicron subvariants after BA.5/BF.7 breakthrough infection weakened as virus evolution and aging despite repeated prototype-based vaccination1.

Journal: Emerging microbes & infections

Published: September 05, 2023

Vaccination Shapes Within-Host SARS-CoV-2 Diversity of Omicron BA.2.2 Breakthrough Infection.

Vaccination Shapes Within-Host SARS-CoV-2 Diversity of Omicron BA.2.2 Breakthrough Infection.

Journal: The Journal of infectious diseases

Published: July 18, 2023

Showing 1-12 of 18

Last Updated: 09/26/2026